Treatment of candidal vaginitis with miconazole, a new broad-spectrum antimycotic. Changes in microbiology, vaginal pH and cytology.
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003883:Arthrodermataceae / Q000187:drug effects; D001593:Benzyl Compounds / Q000494:pharmacology / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects; D002176:Candida albicans / Q000187:drug effects; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000382:microbiology; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004987:Ethers / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D008826:Microbial Sensitivity Tests; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D014626:Vaginal Smears
D000935:Antifungal Agents; D001593:Benzyl Compounds; D004987:Ethers; D007093:Imidazoles